# A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer

> **NCT00731380** · PHASE1 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 12 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** ABI-007

## Key facts

- **NCT ID:** NCT00731380
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00731380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00731380, "A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00731380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*